x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BioBoss

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today"s most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.

science life sciences

All Episodes

30:23

Andrew Hall: CEO of IMV Inc.

BioBoss ·

2022/05/21

Hear Andrew speak with BioBoss host John Simboli about leadership in biopharma and how IMV is working on advancing a portfolio of therapies based on the Company’s immune-educating platform.

en-us

39:47

Kevin Lee: CEO of Bicycle Biotherapeutics

BioBoss ·

2022/04/18

Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.

en-us

27:05

Reenie McCarthy: CEO of Stealth BioTherapeutics

BioBoss ·

2022/03/26

BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.

en-us

40:43

Yochi Slonim: Founder and CEO of Anima Biotech

BioBoss ·

2022/02/05

BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.

en-us

32:36

Clive Richardson: CEO of Akari Therapeutics

BioBoss ·

2022/01/08

BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene pathways

en-us

1:20

Welcome to Season 4 of BioBoss

BioBoss ·

2021/12/28

BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 4.

en-us

38:06

Stefan König: CEO of George Medicines

BioBoss ·

2021/12/04

BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to extend and improve the lives of people suffering from the world’s leading causes of death and disability—including hypertension, cardiovascular disease and type 2 diabetes

en-us

38:12

Derek Maetzold: CEO of Castle Biosciences

BioBoss ·

2021/10/29

Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.

en-us

34:22

Bob Cobuzzi: CEO of Diffusion Pharmaceuticals

BioBoss ·

2021/10/02

Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most.

en-us

38:38

Panna Sharma: CEO of Lantern Therapeutics

BioBoss ·

2021/09/12

Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial intelligence, genomics and machine learning to advance precision oncology therapies.

en-us

44:36

Nandan Padukone: CEO of IM Therapeutics

BioBoss ·

2021/07/31

Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.

en-us

39:20

Matthew Gline: CEO of Roivant Sciences

BioBoss ·

2021/07/10

"I think I've always found motivation from being able to take a highly technical topic and dig in. I'm never the person that knows most about the topic. But I strive to be like the person who knows third or fourth most about whatever topic is going." – Mathew Gline: CEO of Roivant Sciences

en-us

31:19

Koen De Witte: Managing Director of ReMYND

BioBoss ·

2021/05/30

Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.

en-us

36:43

Lanny Sun: Co-founder of Silicon Therapeutics

BioBoss ·

2021/05/01

Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silicon Therapeutics, now part of Roivant Drug Discovery, is advancing its chip-to-clinic, computational quantum physics-based approach to pioneer a new path for drug design of medicines to improve the lives of patients

en-us

36:43

Joan Perelló: Co-Founder and CEO of Sanifit

BioBoss ·

2021/04/03

Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calcification disorders.

en-us

27:15

Saiid Zarrabian: CEO of Kintara Therapeutics

BioBoss ·

2021/03/13

Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for patients with rare unmet medical needs.

en-us

32:05

John Temperato: CEO of 9 Meters Biopharma

BioBoss ·

2021/02/07

John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for patients with rare and unmet gastrointestinal disorders including short bowel syndrome and celiac disease.

en-us

39:58

Shawn Singh: CEO of VistaGen Therapeutics

BioBoss ·

2021/01/10

Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervous system disorders.

en-us

1:08

Welcome to Season 3 of BioBoss

BioBoss ·

2021/01/06

BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 3.

en-us

40:09

Bobby Gaspar: CEO of Orchard Therapeutics

BioBoss ·

2020/12/08

Bobby Gaspar, founder and CEO of Orchard Therapeutics, speaks with BioBoss host John Simboli about leadership and how Orchard Therapeutics is pursuing the opportunity to change medicine and change the lives of people with severe genetic diseases.

en-us

91 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter